Jeanine Roodhart

Associate Professor - medical

Strategic program(s):

Contact

jroodha2@umcutrecht.nl

Pure profile

Research groups

Translational oncology

Research aim

To develop, test, and implement novel therapeutic and diagnostic strategies to combat cancer by integrating fundamental and clinical research.

Go to group

Medical oncology colorectal cancer group

Research aim

To improve outcomes and quality of life for all patients with colorectal and anal cancer by developing and validating biomarkers, enhancing therapeutic strategies, refining patient selection, and studying real life treatment outcomes.

Go to group

Recent publications

All publications

Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, Jeanine M L Roodhart, Geraldine R Vink, Cornelis J A Punt, Anne M May, Miriam Koopman, Jeroen W G Derksen
Current treatment options in oncology, 2024, vol. 25, p.405-426

Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer Jeanine M.L. Roodhart, Miriam Koopman
The Lancet Oncology, 2024, vol. 25, p.1104-1105

Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer Simone van de Weerd, Arezo Torang, Inge van den Berg, Veerle Lammers, Saskia van den Bergh, Nelleke Brouwer, Iris D. Nagtegaal, Miriam Koopman, Geraldine R. Vink, Frederieke H. van der Baan, Han van Krieken, Jan Koster, Jan N. Ijzermans, Jeanine M.L. Roodhart, Jan Paul Medema
International Journal of Cancer, 2024, vol. 156, p.456-466

Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients Yvonne M. Geurts, Femke Peters, Esther Feldman, Jeanine Roodhart, Milan Richir, Jan Willem T. Dekker, Geerard Beets, Jeltsje S. Cnossen, Patricia Bottenberg, Martijn Intven, Marcel Verheij, Kelly M. de Ligt, Iris Walraven
Quality of Life Research, 2024, vol. 33, p.3013-3026

Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months Ingrid A. Franken, Frederieke H. van der Baan, Geraldine R. Vink, Anne M. May, Wilhelmina M.U. van Grevenstein, Miriam Koopman, Jeanine M.L. Roodhart
European Journal of Cancer, 2024, vol. 208

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases K. Zwart, M. N.G.J.A. Braat, F. H. van der Baan, A. M. May, J. M.L. Roodhart, D. Al-Toma, J. M.M.B. Otten, M. Los, T. Oostergo, R. J.A. Fijneman, J. M. van Dodewaard-de Jong, C. J.A. Punt, G. Meijer, J. J.W. Lagendijk, M. Koopman, M. Intven, G. M. Bol
Clinical and translational radiation oncology, 2024, vol. 49, p.1-5

External positions

Consulting Editor Framingham on Gastrointestinal Cancers - selectie meest relevante publicates ogv CRC voor publicatie als samenvatting voor vakgenoten. - framingham publishers

Board member on behalf of UMC Utrecht - lid - Hubrecht Organoid Technology

lid DSMB RADAR PANC studie - expertise als medisch oncoloog/onderzoek - UMC Utrecht

Member of the TC Bio - lid - UMC Utrecht

lid DSMB PELVEX2 studie - expertise als medisch oncoloog - Catharina Ziekenhuis

ONCODE clinical advisory board - expertise als medisch oncoloog/onderzoek - ONCODE

Clinical advisory board - adviserende rol - ONCODE

Editor patient information regarding colorectal cancer - adviseren - Kanker.nl

Steering committee - sturende rol - UPORT